Objective To assess whether the care model (comprehensive vs regular) has any impact on
the clinical outcomes of systemic lupus erythematosus patients. Methods Between August …

Systemic lupus erythematosus (SLE) affects more severely non-White populations, due to
their genetic background and sociodemographic characteristics. Several studies have …

Background Low disease activity state (LDAS) has been linked to a significant reduction in
flares and damage accrual in patients with systemic lupus erythematosus (SLE); however …

Systemic lupus erythematosus (SLE) is a complicated multiorgan disease and can lead to
organ damage and increased risk of morbidity and mortality. The strategy of management …

Introduction: After more than 20 years of sustained work, the Latin American Group for the
Study of Lupus (GLADEL) has made a significant number of contributions to the field of …

Objectives To identify the predictive factors of first hospitalization and associated variables to
the main causes of hospitalizations in lupus patients from a Latin American cohort. Methods …

Objective Previous studies have provided evidence that the discontinuation of
hydroxychloroquine (HCQ), and chloroquine (CQ), in patients with systemic lupus …

Objective Recurrent disease flare is one of the key problems in lupus patients. A Chinese
Flare-Prevention Lupus Initiative Cohort (FLIC) was established. Risk factors of disease flare …

The primary aim of this study was to assess demographic, clinical, and serological factors
associated with remission in systemic lupus erythematosus (SLE). A retrospective cohort …

We read with much interest the contribution of Oon et al 1 that was published recently in
Annals of the Rheumatic Diseases, describing attainment of the lupus low-disease activity …